Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHUT: High vs Standard Dose Urokinase for Dysfunctional Dialysis Catheters
NCT06802679Phase 4Completed
- Sponsor
- National HealthCare Corporation
- Start
- Oct 2020
- Primary completion
- Jan 2025
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of urokinase in catheter dysfunction, sponsored by National HealthCare Corporation. Started Oct 2020; status: completed.
02
Drugs
urokinase
03
Conditions
catheter dysfunction
Beyond the preview
Go deeper on NCT06802679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06802679.